|November 8, 2012|
|08:50 EDT||HNT||Health Net upgraded to Market Perform from Underperform at BMO Capital|
BMO Capital upgraded Health Net based on improved Medi-Cal contracting visibility. Price target is $23.
News For HNT From The Last 14 Days
Check below for free stories on HNT the last two weeks.
|August 26, 2014|
|08:30 EDT||HNT||Health Net Federal Services receives URAC disease management reaccreditation|
Subscribe for More Information
|August 20, 2014|
|08:31 EDT||HNT||Cognizant deal with Health Net has encouraging read through, says Cowen|
Cowen noted Cognizant (CTSH) shareholders were concerned over its deal with Health Net (HNT) but noted management feels the deal is a true partnership. The firm feels management's positive comments are encouraging and address the execution and profitability concerns of shareholders. Shares of Cognizant are Outperform rated with a $50 price target.
|August 19, 2014|
|08:32 EDT||HNT||Health Net says CFO Joseph Capezza to retire|
Health Net announced that James Woys has been named executive vice president, chief financial and operating officer, and interim treasurer, effective September 2. This is a new position. Woys has been executive vice president and COO since November 2007. Previously Woys served as acting CFO from November 2006 through October 2007. The company announced that Joseph C. Capezza, currently executive vice president, CFO and treasurer, will retire as CFO. He will have a consulting contract with the company through year end to assist with transition issues. Capezza has been Health Netís CFO since November 2007.
|August 18, 2014|
|09:00 EDT||HNT||Health Net fundamentals remain favorable, says Susquehanna|
Susquehanna said Health Net (HNT) fundamentals remain favorable following meetings with management. The firm cited the company's conservative outlook and the benefit of its back office contract with Cognizant (CTSH) which positions the company well for sustainable earnings growth through 2016. Shares of Health Net remain Positive rated with a $55 price target on the shares.